ENLIVEN THERAPEUTICS last closed at $45.47 (-3.19%) on 2026-10-05. Signals today: RSI rebound. Listed on Nasdaq. Trailing 12 months PER is -28.4×. Its overall grade ranks 45 of 741 stocks in Healthcare.
About this company
ENLIVEN THERAPEUTICS last closed at $45.47 (-3.19%) on 2026-10-05. Signals today: RSI rebound. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 45/741
Valuation grade A+
Related stocks
- Bristol Myers SquibbCompetitor
항암·혈액암 치료제 개발에서 경쟁 가능한 대형 제약사
- MerckCompetitor
종양학 파이프라인과 면역항암제 분야의 주요 경쟁사
- AmgenCompetitor
항암제·표적치료제 영역에서 경쟁하는 대형 바이오텍
ETFs holding this stock
Innovator IBD Breakout Opportunities ETF · SPDR S&P Pharmaceuticals ETF
Details →About ENLIVEN THERAPEUTICS
- What technical signals does ENLIVEN THERAPEUTICS (ELVN) have?
- ENLIVEN THERAPEUTICS current technical signals: RSI rebound.
- Is ENLIVEN THERAPEUTICS a cup-and-handle pattern?
- No. ENLIVEN THERAPEUTICS has no valid Cup signal right now.
- What published figures are available for ENLIVEN THERAPEUTICS?
- Market cap: $2.7B. Trailing 12 months PER: -28.4×. Latest quarter PBR: 3.36×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about ENLIVEN THERAPEUTICS, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.